|Articles|February 16, 2018
Impact of Gene Therapy Highlights SPT Week in Review
Author(s)SPT Staff
Top news of the week from Specialty Pharmacy Times.
Advertisement
5. Government Report Outlines Steps to Address Rising Drug Costs
A recent report highlights how Americans pay more for prescription drugs compared with other countries.
4. Generic Drug Approved for Relapsing Multiple Sclerosis
G
eneric glatiramer acetate injection is now available in a full range of dosing options for multiple sclerosis.
3. New York Governor Tackles Flu Epidemic Through Increased Pharmacist Involvement
An executive order allows New York pharmacists to administer the influenza vaccine to children.
2. Pharmacists Say DIR Fees Endanger Pharmacies, Patients
Approximately 78% of survey respondents said that direct and indirect remuneration fees reduce the predictability of cash flow.
1. Kymriah Treatment Pulls Young Leukemia Patient from the Darkness
Tisagenlecleucel (Kymriah) induced remission in a patient with acute lymphoblastic leukemia who was seemingly out of options.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Announces Recall 580,000 Bottles of Prazosin Over Potential Carcinogenic Impurity
2
Regular Melatonin Supplementation May Hide Hidden Heart Complications
3
From Type 1 to Type 2 and Beyond: Navigating the Landscape of Diabetes
4
What Health Care Professionals Should Know About Early Type 1 Diabetes Screening
5
